Skip to content

SCHEDULE 13GAccepted Apr 1, 5:00 PM ET

Aprea Therapeutics, Inc. SCHEDULE 13G

Soleus Private Equity Fund III, L.P.

Accepted (ET)

5:00 PM

Apr 1, 2026

Filed

Apr 1, 2026

Documents

2

Size

80.8 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.